Some of the world's largest companies rely on Will Lavery's extensive experience in major “bet the company” private and government antitrust litigations, criminal and civil antitrust investigations, and mergers. Clients in industries including pharmaceutical, healthcare, technology, chemical, energy, and transportation seek Will's guidance in cases alleging a broad range of antitrust violations, including price-fixing, monopolization, Robinson-Patman violations, and sham litigation. Many of these litigations have involved nationwide class action claims for both direct and indirect purchaser plaintiffs—seeking billions of dollars in damages—as well as suits brought by federal and state governments.
Will has significant trial experience in federal courts throughout the country. Recently Will was a member of the trial team that resulted in dismissals of six of the seven price-fixing and monopolization charges for McWane, Inc. in a recent eight-week bench trial against the FTC. The dismissals marked the first time in almost 20 years that the Commission ruled against itself following an in-house trial in front of the ALJ. The case earned the McWane trial team the award for “Behavioral Matter of the Year- Americas” by Global Competition Review in 2015.
Will has also been recognized as a leading antitrust practitioner by The Legal 500 (2017-2020) and Super Lawyers (2014-2020), as well as being named a "Rising Star" by Law360 (2016) as one of the top competition lawyers under 40 in the country and a "Next Generation" partner by The Legal 500.